On October 25, 2024, Homburger advised Molecular Partners, a clinical-stage biotechnology company, in the announcement of the pricing of an underwritten public offering. The offering consisted of 3,642,988 American Depositary Shares (ADSs), representing new shares, priced at $5.49 per
Tags :Molecular Partners
Homburger advised Molecular Partners in this transaction with a team led by partner Dieter Gericke. Bär & Karrer acted as legal counsel to the banking syndicate. The team included partner Thomas Reutter
